Related Experiment Video
Updated: Aug 11, 2026
11:15
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
Classification of AML by DNA-oligonucleotide microarrays
Alexander Kohlmann1, Wolfgang Kern, Wolfgang Hiddemann
1Laboratory for Leukemia Diagnostics, Department of Internal Medicine III, Ludwig-Maximilians-University, Munich, Germany.
Methods in Molecular Medicine
|March 1, 2006
Summary
Gene expression profiling using microarrays can enhance leukemia diagnosis and classification. This method improves accuracy and efficiency for better patient management.
Area of Science:
- Hematology
- Molecular Biology
- Genomics
Background:
- Accurate leukemia diagnosis and classification are crucial for effective patient management.
- Current diagnostic methods may have limitations in accuracy and efficiency.
- Microarray technology offers potential for improving leukemia diagnostics.
Purpose of the Study:
- To provide an overview of gene expression profiling for leukemia samples.
- To describe the laboratory procedures involved in gene expression profiling.
- To outline approaches for analyzing gene expression data in leukemia.
Main Methods:
- Gene expression profiling using microarray technology.
- Detailed laboratory procedures for sample processing and hybridization.
- Bioinformatic approaches for analyzing high-throughput gene expression data.
Main Results:
- Gene expression profiling provides a comprehensive molecular signature of leukemia subtypes.
- The method allows for improved differentiation between various leukemia types.
- Data analysis strategies are essential for extracting meaningful diagnostic information.
Conclusions:
- Microarray-based gene expression profiling is a powerful tool for leukemia diagnosis and classification.
- This approach has the potential to significantly improve diagnostic accuracy and efficiency.
- Further integration of gene expression data can lead to optimized patient management strategies.
